| Dziewierz A, Siudak Z, Rakowski T, et al.
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction Data from the EUROTRANSFER registry. [JOURNAL ARTICLE]
Int J Cardiol 2009 Jun 24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Speich HE, Earhart AD, Hill SN, et al.
Variability of platelet aggregate dispersal with glycoprotein IIb-IIIa antagonists eptifibatide and abciximab. [Journal Article]
J Thromb Haemost 2009 Jun; 7(6):983-91.
Abstract | Full Citation |
| Gibbs NM
Point-of-care assessment of antiplatelet agents in the perioperative period: a review. [Journal Article]
Anaesth Intensive Care 2009 May; 37(3):354-69.
Abstract | Full Citation |
| Rabbani LE, Iyengar S, Dangas GD, et al.
Impact of Thienopyridine Administration Prior to Primary Stenting in Acute Myocardial Infarction. [JOURNAL ARTICLE]
J Interv Cardiol 2009 May 28.
Abstract | Full Citation | Find Related Articles |
| Cohen M
Antiplatelet therapy in percutaneous coronary intervention: A critical review of the 2007 AHA/ACC/SCAI guidelines and beyond. [JOURNAL ARTICLE]
Catheter Cardiovasc Interv 2009 Feb 2.
Abstract | Full Citation |
| Estévez-Loureiro R, Salgado-Fernández J, Marzoa-Rivas R, et al.
Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. [JOURNAL ARTICLE]
Thromb Res 2009 May 19.
Abstract | Full Citation |
| Cuisset T, Frere C, Quilici J, et al.
Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders A Prospective, Randomized Study. [JOURNAL ARTICLE]
JACC Cardiovasc Interv 2008 Dec; 1(6):649-653.
Abstract | Full Citation |
| Małek LA, Bilińska ZT, Sitkiewicz D, et al.
Platelet reactivity on aspirin, clopidogrel and abciximab in patients with acute coronary syndromes and reduced estimated glomerular filtration rate. [JOURNAL ARTICLE]
Thromb Res 2009 May 12.
Full Citation | Find Related Articles |
| Brener SJ
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? [Comment, Editorial]
J Am Coll Cardiol 2009 May 5; 53(18):1674-6.
Full Citation | Publisher Full Text | Find Related Articles |
| De Luca G, Ucci G, Cassetti E, et al.
Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. [Comparative Study, Journal Article, Meta-Analysis]
J Am Coll Cardiol 2009 May 5; 53(18):1668-73.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
